Details

---

Manufacturer
Duopharma (M) Sdn. Bhd., Malaysia

Registration Number (MAL): MAL19985971AZ

Active Ingredient: Ranitidine Hydrochloride (equivalent to 50 mg of Ranitidine per 2 ml)
 

Indications

Gastril Injection is indicated for:

• Treatment of peptic ulcer disease (PUD), including duodenal and benign gastric ulcers

• Management of gastroesophageal reflux disease (GERD)

• Prophylaxis of gastrointestinal hemorrhage from stress ulceration

• Prevention of acid aspiration during general anesthesia

• Treatment of Zollinger-Ellison syndrome and other hypersecretory conditions

Instructions for Use

• Dosage and Administration: Administer via intravenous (IV) or intramuscular (IM) injection.

  • IV Injection: Dilute 2 ml of Gastril Injection with 0.9% Sodium Chloride Injection to a total volume of 5–10 ml. Inject over a period of not less than 2 minutes.

  • IV Infusion: Dilute 2 ml of Gastril Injection with 100 ml of 5% dextrose or other compatible solution. Infuse over 15–30 minutes.

• Dosage Adjustments: In patients with renal impairment, reduce the dose or extend the dosing interval to prevent accumulation.

• Storage: Store at room temperature, away from light and moisture.